Teva Pharmaceutical (NYSE:TEVA) shares have risen for seven consecutive sessions, as the stock closed up about 1% at $22.42 on Tuesday.
Shares of the Israeli drugmaker rose 34.5% in the previous six sessions. The stock has more than doubled so far this year, climbing nearly 115%, which is less